Theravance Bio Ord (TBPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 89,215 | 122,228 | 268,199 | N/A | N/A |
| Marketable Securities | 165,396 | 162,489 | 80,997 | N/A | N/A |
| Receivables | 2,129 | 411 | 15,335 | 93 | 1,133 |
| Inventories | 12,546 | 15,129 | 14,756 | 11,014 | 10,406 |
| TOTAL | $275,370 | $306,711 | $382,733 | $15,600 | $14,106 |
| Non-Current Assets | |||||
| PPE Net | 9,663 | 9,356 | 9,624 | 9,734 | 10,238 |
| Investments And Advances | 51,399 | 65,638 | 38,231 | 0 | 0 |
| Other Non-Current Assets | 1,339 | 0 | 0 | 833 | 833 |
| TOTAL | $62,401 | $74,994 | $47,855 | $10,567 | $11,071 |
| Total Assets | $337,771 | $381,705 | $430,588 | $26,167 | $25,177 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,921 | 5,284 | 9,499 | 4,984 | 6,940 |
| Accrued Expenses | 18,156 | 10,886 | 6,482 | 13,417 | 9,870 |
| TOTAL | $41,256 | $35,828 | $40,111 | $38,544 | $36,853 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 89 | 667 | 5,723 | 7,732 | 8,207 |
| Other Non-Current Liabilities | 1,578 | 986 | 0 | 0 | 585 |
| TOTAL | $6,728 | $6,056 | $5,718 | $5,539 | $5,359 |
| Total Liabilities | $47,984 | $41,884 | $45,829 | $44,083 | $42,212 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 33,802 | 32,228 | 32,233 | 32,260 | N/A |
| Retained earnings | -139,337 | -75,027 | -20,532 | -17,916 | -17,035 |
| Other shareholders' equity | -82 | -27 | 70 | 0 | 0 |
| TOTAL | $289,787 | $339,821 | $384,759 | $-17,916 | $-17,035 |
| Total Liabilities And Equity | $337,771 | $381,705 | $430,588 | $26,167 | $25,177 |